IRADIMED CORP — Director's Dealing 2019

Aug 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2019-08-19

Reporting Person: McDonnell Leslie L (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-19	Restricted Stock Units	$	A	94652	Acquired		Common Stock (94652)	Direct
2019-08-19	Stock Option (Right to Buy)	$21.13	A	50000	Acquired	2029-08-19	Common Stock (50000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F3: This option was granted on 8/19/2019 and vests over four years in equal annual installments commencing on the first anniversary of the grant date.